[1]
|
Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature, 1988; 332, 78-81. doi: 10.1038/332078a0 |
[2]
|
Tamura N, Ogawa Y, Yasoda A, et al. Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes. J Mol Cell Cardiol, 1996; 28, 1811-5. doi: 10.1006/jmcc.1996.0170 |
[3]
|
Sudoh T, Maekawa K, Kojima M, et al. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun, 1989; 159, 1427-34. doi: 10.1016/0006-291X(89)92269-9 |
[4]
|
Gunning M, Ballermann BJ, Silva P, et al. Brain natriuretic peptide: interaction with renal ANP system. Am J Physiol, 1990; 258, F467-72. http://ajprenal.physiology.org/content/258/3/F467 |
[5]
|
St Pierre L, Flight S, Masci PP, et al. Cloning and characterisation of natriuretic peptides from the venom glands of Australian elapids. Biochimie, 2006; 88, 1923-31. doi: 10.1016/j.biochi.2006.06.014 |
[6]
|
Scott NJ, Ellmers LJ, Lainchbury JG, et al. Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development. Biochim Biophys Acta, 2009; 1792, 1175-84. doi: 10.1016/j.bbadis.2009.09.009 |
[7]
|
Thejus J, Francis J. N-terminal pro-brain natriuretic peptide and atrial fibrillation. Indian Pacing Electrophysiol J, 2009; 9, 1-4. http://www.oalib.com/paper/2468364#.WWwlIflJJpY |
[8]
|
Liang F, O'Rear J, Schellenberger U, et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol, 2007; 49, 1071-8. doi: 10.1016/j.jacc.2006.10.063 |
[9]
|
Lam CS, Burnett JC Jr, Costello-Boerrigter L, et al. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population. J Am Coll Cardiol, 2007; 49, 1193-202. doi: 10.1016/j.jacc.2006.12.024 |
[10]
|
Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive aminoterminal pro-brain natriuretic-proBNP): a new marker of cardiac impairment. Clin Endocrinol, 1997; 47, 287-97. doi: 10.1046/j.1365-2265.1997.2361058.x |
[11]
|
Sabatasso S, Vaucher P, Augsburger M, et al. Sensitivity and specificity of NT-proBNP to detect heart failure at post mortem examination. Int J Leg Med, 2011; 125, 849-56. doi: 10.1007/s00414-011-0581-6 |
[12]
|
Zhang J, Shu YG. Highly sensitive detection of NT-proBNP by molecular motor. Genes & Diseases, 2017; 4, 37-40. https://www.researchgate.net/publication/310839036_Highly_sensitive_detection_of_NT-proBNP_by_molecular_motor |
[13]
|
Gunning M, Brenner BM. Urodilatin: a potent natriuretic peptide of renal origin. Curr Opin Nephrol Hypertens, 1993; 2, 857-62. doi: 10.1097/00041552-199311000-00001 |
[14]
|
Yang H, Li D, He R, et al. A novel quantum dots-based point of care test for syphilis. Nanoscale Res Lett, 2010; 5, 875-81. doi: 10.1007/s11671-010-9578-1 |
[15]
|
Shen H, Yuan H, Niu JZ, et al. Phosphine-free synthesis of high-quality reverse type-I ZnSe/CdSe core with CdS/Cd(x)Zn(1 -x)S/ZnS multishell nanocrystals and their application for detection of human hepatitis B surface antigen. Nanotechnology, 2011; 22, 375602. doi: 10.1088/0957-4484/22/37/375602 |
[16]
|
Worsley GJ, Attree SL, Noble JE, et al. Rapid duplex immunoassay for wound biomarkers at the point-of-care. Biosens Bioelectron, 2012; 34, 215-20. doi: 10.1016/j.bios.2012.02.005 |
[17]
|
Nabatiyan A, Baumann MA, Parpia Z, et al. A lateral flow-based ultra-sensitive p24 HIV assay utilizing fluorescent microparticles. J Acquir Immune Defic Syndr, 2010; 53, 55-61. doi: 10.1097/QAI.0b013e3181c4b9d5 |
[18]
|
Ahn JS, Choi S, Jang SH, et al. Development of a point-of-care assay system for high-sensitivity C-reactive protein in whole blood. Clin Chim Acta, 2003; 332, 51-9. doi: 10.1016/S0009-8981(03)00113-X |
[19]
|
Swanson C, D'Andrea A. Lateral flow assay with near-infrared dye for multiplex detection. Clin Chem, 2013; 59, 641-8. doi: 10.1373/clinchem.2012.200360 |